Cannabinoid-induced poisonings are leading to more hospital admissions as drug traffickers target puff bars, gummies, and ...

Poisonings linked to synthetic and semisynthetic cannabinoids (man-made products designed to mimic cannabis) are increasing ...

VIP36, a new CB1 agonist, targets a cryptic pocket to provide analgesia for chronic pain while minimizing side effects and ...

The drug was linked to an incident in a Cork town ... HHC is a semi-synthetic version of a natural cannabinoid found in cannabis, emulating the effects of THC in cannabis plants.

The way they did it was to design a custom, synthetic cannabinoid molecule that is positively charged, which prevents it from being able to cross the blood-brain barrier. This means it can’t bind to ...

In this edition of “Rising High,” The Fly conducted an exclusive interview with Jared Stanley, Chief Executive Officer, and Joel Stanley, ...

This means it can’t bind to its target – cannabinoid receptor 1 (CB1 ... and are planning the development of an oral drug that will hopefully make it to human clinical trials.

The substance, hexahydrocannabinol, has never previously been scheduled. The US abstained for reasons unclear.

Hexahydrocannabinol (HHC) is a ‘cannabinoid’ product that emerged in Europe three-years ago and more and more teenagers are ...